These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6537690)
1. Effect of calcitonin on hemodialysis patients with hypercalcemia and renal osteodystrophy. Carney SL; Epstein MT Uremia Invest; 1984-1985; 8(2):97-101. PubMed ID: 6537690 [TBL] [Abstract][Full Text] [Related]
2. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697 [TBL] [Abstract][Full Text] [Related]
3. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism]. Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839 [TBL] [Abstract][Full Text] [Related]
4. Renal osteodystrophy in dialysis patients: diagnosis and treatment. Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690 [TBL] [Abstract][Full Text] [Related]
5. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy]. Bucciante G; Bernardi A; Biasia F; Milan G; Donato D Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698 [No Abstract] [Full Text] [Related]
6. A trial of calcitonin therapy in renal osteodystrophy. Delano BG; Baker R; Gardner B; Wallach S Nephron; 1973; 11(5):287-93. PubMed ID: 4753519 [No Abstract] [Full Text] [Related]
7. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients. Piraino B; Chen T; Puschett JB Am J Nephrol; 1989; 9(3):190-7. PubMed ID: 2757078 [TBL] [Abstract][Full Text] [Related]
8. Effect of CAPD and hemodialysis on parathyroid function. Malberti F; Corradi B; Imbasciati E Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912 [TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
11. Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy? Ionova D; Zlatarska S; Kirjakov Z Nephrol Dial Transplant; 1995; 10(9):1782. PubMed ID: 8559512 [No Abstract] [Full Text] [Related]
12. [Influence of vitamin D therapy on renal osteodystrophy in children (author's transl)]. Bulla M; Stock GJ; Delling G; Hofmann H; Offermann G Klin Wochenschr; 1980 Mar; 58(5):237-47. PubMed ID: 6249957 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy]. Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699 [No Abstract] [Full Text] [Related]
14. Calcium metabolism in renal failure. David DS Am J Med; 1975 Jan; 58(1):48-56. PubMed ID: 1090150 [TBL] [Abstract][Full Text] [Related]
15. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients. Wang SX; Li H Chin Med J (Engl); 2008 Jul; 121(14):1280-4. PubMed ID: 18713548 [TBL] [Abstract][Full Text] [Related]
16. [Correlations between osteodensitometry and parameters of uremic osteodystrophy]. Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703 [No Abstract] [Full Text] [Related]
17. [Calcitonin for therapy of renal osteodystrophy due to long-term hemodialysis in patients with chronic kidney failure]. Ishida M; Yamada M Nihon Rinsho; 1991 Dec; 49 Suppl():725-31. PubMed ID: 1808343 [No Abstract] [Full Text] [Related]